The neutrophil‐to‐lymphocyte ratio in salivary gland cancers treated with pembrolizumab
出版年份 2023 全文链接
标题
The neutrophil‐to‐lymphocyte ratio in salivary gland cancers treated with pembrolizumab
作者
关键词
-
出版物
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-28
DOI
10.1002/hed.27565
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A molecular guide to systemic therapy in salivary gland carcinoma
- (2023) Alice N. Weaver et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Neutrophil‐to‐lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta‐analysis
- (2022) Yukinori Takenaka et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study
- (2022) Caroline Even et al. EUROPEAN JOURNAL OF CANCER
- Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostat
- (2022) Cassie Pan et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Approaches to the Management of Metastatic Adenoid Cystic Carcinoma
- (2022) Rex H. Lee et al. Cancers
- PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols
- (2021) Simona Crosta et al. Cancers
- Anti-PD-1 Immune Checkpoint Blockade for Head and Neck Cancer
- (2021) Christopher A. Maroun et al. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA
- The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype
- (2020) Luc GT Morris et al. CLINICAL CANCER RESEARCH
- Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio in Mucoepidermoid Carcinoma of Pediatrics: A Multicenter Study
- (2020) Hua Gao et al. Frontiers in Pediatrics
- Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma
- (2020) Kazutomo Niwa et al. Scientific Reports
- Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Pediatric Parotid Cancer
- (2019) Dongjie Seng et al. Frontiers in Pediatrics
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- Cancer related circulating and tumor-associated neutrophils - subtypes, sources and function
- (2018) Merav E. Shaul et al. FEBS Journal
- Pretherapeutic assessment of hematologic and inflammatory markers in adenoid cystic carcinoma: neutrophil/lymphocyte ratio is associated with multiple recurrences
- (2018) Faris F. Brkic et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Clinical significance of tumor-infiltrating lymphocytes in breast cancer
- (2016) Sasha E. Stanton et al. Journal for ImmunoTherapy of Cancer
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- Tumor-Associated Neutrophils: New Targets for Cancer Therapy
- (2011) A. D. Gregory et al. CANCER RESEARCH
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started